$0.1658
N/A
Last update: Nov 9, 6:55 PM
Arcadia Biosciences Inc
RKDANASDAQ
The average analyst price target for Arcadia Biosciences is $6, 3518.8% above the current price. The one analyst covering it rates it Buy. The latest change came on May 23, 2024, when HC Wainwright & Co. lowered its price target on Arcadia Biosciences from $10 to $6 and kept a Buy rating.
Price Target Range — 2 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
